Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

aromatic L-amino acid decarboxylase deficiency News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A first-in-human pediatric dose-escalation study demonstrates the co-delivery of AADC and GDNF via intraputaminal AAV9 in patients with severe AADC deficiency. This research could pave the way for innovative gene therapies targeting this rare condition.

A recent study highlights the mild form of aromatic L-amino acid decarboxylase deficiency, contributing to the understanding of this rare metabolic disorder. This research may inform future therapeutic strategies and patient management.

Not rare diseases news,news about your rare disease.

Earlier

A first-in-human pediatric dose-escalation study demonstrates the co-delivery of AADC and GDNF via intraputaminal AAV9 in patients with severe AADC deficiency. This research could pave the way for innovative gene therapies targeting this rare condition.

A recent study highlights the mild form of aromatic L-amino acid decarboxylase deficiency, contributing to the understanding of this rare metabolic disorder. This research may inform future therapeutic strategies and patient management.

Not rare diseases news,
news about your rare disease.